Schistosoma mansoni: Genetic Complementation Analysis Shows That Two Independent Hycanthone/Oxamniquine-Resistant Strains Are Mutated in the Same Gene

1993 ◽  
Vol 77 (4) ◽  
pp. 445-449 ◽  
Author(s):  
L. Picamattoccia ◽  
L.C.D. Dias ◽  
R. Moroni ◽  
D. Cioli
Parasitology ◽  
1986 ◽  
Vol 92 (3) ◽  
pp. 653-664 ◽  
Author(s):  
C. J. Bayne ◽  
E. S. Loker ◽  
Mary A. Yui

SUMMARYThe tegumental surface of Schistosoma mansoni sporocysts is the site of both nutritive and immunological interactions with haemolymph cells and plasma of Biomphalaria glabrata, the schistosome intermediate host. Within minutes of being placed in host plasma, sporocysts acquire plasma antigens, and within 3 h host plasma antigens are present on the surface at near steady state. Though a wide variety of peptides is acquired, there is selection. Furthermore, some differences occur in the peptides acquired from the plasma of susceptible and resistant strains of snail. Acquired antigens are rapidly processed, and are predominantly undetectable in tegumental extracts after a few hours. In contrast, rabbit antibody on sporocysts remains in situ for at least 48 h, so under some conditions there is stable expression of certain tegumental antigenic determinants.These data, obtained using antibodies to snail plasma antigens and to sporocyst tegumental antigens, are discussed in the light of current ideas on the cellular and molecular basis of susceptibility and resistance in this host#parasite system.


Author(s):  
D. Bootsma ◽  
E. A. De Weerd-Kastelein ◽  
W. J. Kleijer ◽  
W. Keÿzez

1997 ◽  
Vol 39 (4) ◽  
pp. 197-202 ◽  
Author(s):  
F. S. de M. BEZERRA ◽  
J. A. NOGUEIRA-MACHADO ◽  
M. M. CHAVES ◽  
R. L. MARTINS ◽  
P. M. Z. COELHO

Among the determinant factors in the resistance and susceptibility of Biomphalaria to Schistosoma mansoni, hemocytes play an important role. Aiming at studying S. mansoni/Biomphalaria interactions related to hemocytes, the first step is certainly connected with the standardization of this cell population in uninfected Biomphalaria. In this way, quantification of this cell population in hemolymph, as well as its phagocitary capacity, have been determined for the first time. Furthermore, using susceptible and resistant strains of B. glabrata and B. tenagophila, the hemocytegram and phagocytary capacity of hemocytes after infection with S. mansoni were determined too. Resistant and susceptible strains of B.glabrata (BA and BH, respectively), as well as resistant and susceptible strains of B. tenagophila (Taim and CF, respectively) were infected with 10 miracidia of the LE and SJ strains of S. mansoni, respectively. These infected snails and respective uninfected controls were assessed in relation to the number of circulating hemocytes and alteration in the phagocytary capacity, by using Zymozan and MTT. Reading was taken by means of a spectrophotometer at 5 hours and 1,2,5,10,20 and 30 days after infection. The results showed a decrease in population of the circulating phagocytary cells, 5 hours after infection. One day post-infection, the circulating cells of the susceptible snails showed an increased metabolic activity, but the same event could not be observed in the resistant strains. In the subsequent observation periods, significant differences among the strains studied could not be observed until the end of the experiment


Author(s):  
Luiz Candido de Souza Dias ◽  
John I. Bruce ◽  
Gerald C. Coles

Five strains of Schistosoma mansoni resistant and susceptible to schistosomicides were studied for infectivity of 2 strains of Biomphalaria glabrata one of Puerto Rican origin and the other of Brazilian origin. Puerto Rican strains of S. Mansoni developed more slowly and had a lower infectivity in Brazilian B. glabrata than did the Brazilian S. mansoni. However, Brazilian S. Mansoni developed as well in Puerto Rican snails as in Brazilian snails, indicating that drug resistant strains could easily be moved by travel of infected persons from one area to another.


2016 ◽  
Vol 59 (3) ◽  
pp. 231-237 ◽  
Author(s):  
Joon-Seob Eom ◽  
Cong Danh Nguyen ◽  
Dae-Woo Lee ◽  
Sang-Kyu Lee ◽  
Jong-Seong Jeon

F1000Research ◽  
2019 ◽  
Vol 8 ◽  
pp. 651 ◽  
Author(s):  
Benson Otarigho

Background: Praziquantel, as the only drug for the treatment of schistosomiasis, is under serious threat due to the emergence of resistant strains of Schistosoma species. There is an urgent need to search for alternative chemotherapy to supplement or complement praziquantel. Schistosoma dihydroorotate dehydrogenase (DHODH) has been recommended as a druggable target for schistosomiasis chemotherapy. The development of novel molecular modeling approaches, alongside with computational tools and rapid sequencing of pathogen genomes, have facilitated drug discovery. Therefore, the aim of this study was to employ computational approaches to screen compounds against Schistosoma mansoni DHODH. Methods: In this study, DHODH was used to blast on the latest version of DrugBank that contained 12,110 compounds, resulting in 26 drugs that can bind. Results: In silico docking shows that 13 drugs can bind strongly with an estimated free energy of binding, total intermolecular energy and estimated inhibition constant (Ki) greater than or equal to -8.6 kcal/mol, -8.12 kcal/mol and 1.12 µM, respectively. These compounds include the approved drugs manitimus, capecitabine, brequinar analog and leflunomide. Conclusions: These results indicate that these drugs have the potential for use in the control of schistosomiasis in the future.


1977 ◽  
Vol 130 (1) ◽  
pp. 506-511 ◽  
Author(s):  
L M Swaney ◽  
Y P Liu ◽  
K Ippen-Ihler ◽  
C C Brinton

Sign in / Sign up

Export Citation Format

Share Document